GeneOne Life Science, Inc. Logo

GeneOne Life Science, Inc.

Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.

011000 | KO

Overview

Corporate Details

ISIN(s):
KR7011000007
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 20층(여의도동, 파크원NH금융타워(타워2)), 서울특별시

Description

GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-23 00:00
소송등의판결ㆍ결정
Korean 6.5 KB
2025-07-16 00:00
벌금등의부과
Korean 5.7 KB
2025-07-14 00:00
[기재정정]주주총회소집결의
Korean 25.6 KB
2025-07-03 00:00
[기재정정]주주총회소집결의
Korean 11.1 KB
2025-07-02 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 5.3 KB
2025-06-30 00:00
불성실공시법인지정
Korean 6.7 KB
2025-06-20 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 6.4 KB
2025-06-20 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 6.4 KB
2025-06-18 00:00
기타경영사항(자율공시)
Korean 4.4 KB
2025-06-18 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 6.8 KB
2025-06-16 00:00
기타경영사항(자율공시)
Korean 4.1 KB
2025-06-16 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 6.0 KB
2025-06-04 00:00
불성실공시법인지정예고
Korean 6.2 KB
2025-05-30 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 12.5 KB
2025-05-29 00:00
[기재정정]주주총회소집결의
Korean 10.1 KB

Automate Your Workflow. Get a real-time feed of all GeneOne Life Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GeneOne Life Science, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GeneOne Life Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.